OUR
PORTFOLIO
The Verity Pharmaceuticals portfolio focuses on clinically relevant, in-demand prescription therapeutics for the benefit of healthcare providers and their patients across a range of therapeutic areas including Urology, Oncology, Infectious Disease, and Men’s and Women’s Health.
Brands
TLANDO® is a testosterone replacement therapy approved for use in adult males and is indicated for conditions associated with a deficiency or absence of endogenous testosterone: primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired).
TLANDO® Prescribing Information
To learn more about TLANDO® or to order TLANDO® visit www.tlando.com
Trelstar® is a gonadotropin-releasing hormone (GnRH) agonist approved for use in the United States for patients with prostate cancer.
Trelstar® Prescribing Information
To learn more about Trelstar® or to order Trelstar® visit www.trelstar.com
Partnered Brands in Puerto Rico
Akynzeo® is the first and only 5-HT3 and NK1 receptor antagonists fixed combination approved for the prevention of chemotherapy-induced acute and delayed nausea and vomiting.
Akynzeo Prescribing Information
To learn more about Akynzeo® visit www.helsinn.com
Valchlor® is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides‐type cutaneous T‐cell lymphoma in patients who have received prior skin‐directed therapy.
Valchlor Prescribing Information
To learn more about Valchlor® visit www.valchlor.com
Vibativ® (telavancin) is an FDA-approved injectable antibiotic used in the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
Vibativ Prescribing Information
To learn more about Vibativ® visit www.vibativ.com
TRELSTAR® and its designs are licensed trademarks of Verity Pharmaceuticals, Inc.
AKYNZEO is a registered trademark of Helsinn Healthcare SA, Lugano, Switzerland
VALCHLOR® is a registered trademark of Helsinn Birex Pharmaceuticals Ltd., Ireland, distributed and marketed by Helsinn Therapeutics (U.S.), Inc. under license.
VIBATIV® is a registered trademark of Cumberland Pharmaceuticals Inc.